Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency

BACKGROUND: Immunocompromised individuals can become chronically infected with norovirus, but effective antiviral therapies are not yet available. METHODS: Treatments with nitazoxanide, ribavirin, interferon alpha-2a, and nasoduodenally administered immunoglobulins were evaluated sequentially in an...

Descripción completa

Detalles Bibliográficos
Autores principales: van Kampen, Jeroen J A, Dalm, Virgil A S H, Fraaij, Pieter L A, Oude Munnink, Bas B, Schapendonk, Claudia M E, Izquierdo-Lara, Ray W, Villabruna, Nele, Ettayebi, Khalil, Estes, Mary K, Koopmans, Marion P G, de Graaf, Miranda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650502/
https://www.ncbi.nlm.nih.gov/pubmed/35255136
http://dx.doi.org/10.1093/infdis/jiac085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650502/
https://www.ncbi.nlm.nih.gov/pubmed/35255136
http://dx.doi.org/10.1093/infdis/jiac085

Ejemplares similares